ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Merck KGaA Pays $600m For Transfection
ScripJapanese information and communication technology giant Fujitsu has jointly developed an ultra-high throughput drug discovery system it says can not only dramatically reduce R&D lead times but can als
Pink SheetUnlike previous rounds of fast track approval review designations in China, in which oncology drugs took the lead, this time orphan drugs are shining. The latest list of selected products released Mar
ScripA Phase III failure is never good news, but for United Therapeutics Corp. the discontinuation of its investigational oral prostacyclin receptor agonist esuberaprost in combination with its marketed